Cannabis Law Report

FEBRUARY 10, 2022

Despite Petitioners’ noble cause, the case turned on a technicality after the Court determined that the DEA’s letter stating that such psilocybin treatment was not allowed, the document that prompted the lawsuit, was not a “final” decision of the Attorney General that the Court had jurisdiction to review. Background. Psilocybin. The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

SEPTEMBER 23, 2022

Bill sponsor Senator Scott Wiener, who enlisted MAPS to advise on the bill, led the reform closer to passage than any previous state-wide psychedelic decriminalization legislation. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. These campaigns focus on dispelling myths, highlighting success stories, and educating the public about the science behind cannabis-based treatments.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Our main priority is informing national and EU institutions about the opportunity that this treatment is offering,” said Sita Schubert, secretary general of EUMCA.

Medicine 59

Medicine Clinical Trials Treatment Access 59

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Veriheal

MARCH 23, 2023

On Tuesday, January 24, several legislative bills were unveiled by the Japanese government. The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. TOKI currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. Draft Law of Ukraine.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Canna Law Blog

NOVEMBER 6, 2021

Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin. Rescheduling can help solve this problem by promoting larger trials. The first is legislative. Last week in Nature Medicine , I.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

CannaTech

SEPTEMBER 23, 2019

The pleas of parents fighting to treat their sick children are impossible to ignore, as evidenced by the impact of Billy Caldwell and Alfie Dingley’s parents in shifting the regulatory framework for UK cannabis policy. This bottleneck has left patients and parents to pursue unregulated avenues to access treatment.

Patients 79

Patients Policy Clinical Trials Research and Development 79

CannaMD

MARCH 8, 2021

Read on to learn why CannaMD is leading the charge with other physician groups to educate legislators and oppose H.B. Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. 1455 – and how YOU can fight back with research-based arguments! 2, line 32].

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

AUGUST 30, 2019

This is a turnaround from earlier statements Crapo made in opposition to any pro-cannabis legislation. House Judiciary Chairman Jerrod Nadler (D-NY) wrote to NORML members asking for grassroots support for his cannabis legislation, the MORE Act. The SAFE Banking Act (H.R.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). A recent study by Lintzeris et al.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MAY 7, 2021

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization. MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

OCTOBER 3, 2019

Changes to ACT Legislation. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019. The Australian medicinal cannabis industry has received significant commercial, research and policy interest. Key findings. The Final Report found that: 1. Recommendations.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

JULY 15, 2022

But bottlenecks remain to doctors prescribing the controversial treatment. We are at the crossroads of good agriculture meets good health care which meets great policy. ADAM BENJAMIN: If I may add to that, and I believe Australia’s not only got the right legislation here, but the best legislation and the best quality.

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. MSO: Yeah, it’s very different.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

AUGUST 7, 2022

The legislation significantly inhibited research into the potential therapeutic uses of psychedelics for decades. Psychedelic Alpha Policy Map. Psychedelic Alpha, an independent community in the psychedelics space, keeps track of psychedelic drug policy reform across the United States.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Legislative initiatives (introduction and support of changes of laws). Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

Election Night also ushered in new, pro-legalization governors in so-far not legalized Illinois, Connecticut, Maine, Minnesota, and New Mexico, and also saw the defeat of staunch cannabis opponent Pete Sessions, who’s been blocking cannabis legislation for years. RELATED STORY. The Top 10 Cannabis Stories of 2018.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Veriheal

JULY 18, 2023

This article will delve into this historic legislation’s potential benefits and implications. The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. With this step, the U.S. This could foster a pool of experts well-versed in applying psychedelic-assisted therapy.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Cannabis has been legal for medical purposes in Canada since 2001, with several iterations of regulation and legislation shaping the industry over the years.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

Presidents Barack Obama and Donald Trump have voiced support for state governments deciding their own policies. The good news for Kentucky legislators is the data already i s available. In that time around a dozen other states have passed medical bills, eight more have joined Colorado and Washington in full legalization.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JUNE 30, 2019

The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction. Although the amendments represent an unprecedented level of support for pro-cannabis policies in the House, a similar level of support in the Republican-controlled Senate is unlikely.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

JANUARY 14, 2020

Legislation. Senior Policy Advisor, Diversion Control Division. It would also open up medical marijuana access to veterans, allowing Department of Veterans Affairs health providers to “provide information to veterans about federally-approved cannabis clinical trials, and to participate in such trials if registered under the CSA.”.

Clinical Trials 69

Clinical Trials Programs Access DEA 69